Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.49 USD
-0.04 (-2.61%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.49 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACET 1.49 -0.04(-2.61%)
Will ACET be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ACET based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACET
Why Adicet Bio (ACET) Stock Might be a Great Pick
Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
ACET: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD
Other News for ACET
Adicet Bio: Microcap With A High Risk To Reward Ratio
JMP Securities Sticks to Their Hold Rating for Adicet Bio (ACET)
Adicet Bio (ACET) Receives a Buy from Truist Financial
Analysts Offer Insights on Healthcare Companies: Precision BioSciences (DTIL) and Adicet Bio (ACET)
Wall Street Analysts Are Bullish on Top Healthcare Picks